SHANGHAI, Nov. 6 /PRNewswire-Asia-FirstCall/ -- Chemspec International
Limited (NYSE: CPC; "Chemspec" or the "Company"), a leading China-based
contract manufacturer of highly-engineered specialty chemicals, today
announced that it will attend following upcoming investor conferences in
November, 2009.
Credit Suisse China Investment Conference
Event: One-on-One meetings
Date and time: November 16-17, 2009
Location: Shenzhen InterContinental
Participants: Carol Fang, Investor Relations Manager
Oppenheimer 4th Annual Industrials Conference
Event: Formal Presentation, Q&A, One-on-One meetings
Date: November 17-18, 2009
Location: Room 5.07
Millennium Broadway, New York City
Presentation Time: 9:30 a.m. Wednesday, November 18, 2009
Participants: Bing Zhu, Chief Financial Officer
2009 Brean Murray China Growth Conference
Event: Formal Presentation, Q&A, One-on-One meetings
Date: November 19-20, 2009
Location: Room 3.02
Millennium Broadway, New York City
Presentation Time: 10:40 a.m. Friday, November 20, 2009
Participants: Bing Zhu, Chief Financial Officer
For more information about these three conferences, please contact the
investment banks directly.
About Chemspec
Chemspec is a leading China-based contract manufacturer of highly
engineered specialty chemicals and the largest manufacturer of fluorinated
specialty chemicals in China based on sales. In manufacturing specialty
chemicals, Chemspec also provides process design and process development
services, which enable efficient and rapid production of specialty chemicals
that are incorporated into the products of Chemspec's end users. Chemspec's
customers and end users include electronics, pharmaceutical and agrochemical
companies. For more information, please visit http://www.chemspec.com.cn .
Safe Harbor Statements
This announcement contains forward-looking statements. These statements
constitute "forward-looking" statements within the meaning of Section 27A of
the Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended, and as defined in the U.S. Private
Securities Litigation Reform Act of 1995. These forward-looking statements can
be identified by terminology such as "will," "expects," "anticipates,"
"future," "intends," "plans," "believes," "estimates" and similar statements.
Such statements involve certain risks and uncertainties that could cause
actual results to differ materially from those in the forward-looking
statements. Further information regarding these and other risks is included in
Chemspec's filings with the U.S. Securities and Exchange Commission, including
its registration statement on Form F-1, as amended from time to time. Chemspec
does not undertake any obligation to update any forward-looking statement,
except as required under applicable law.
For further information, please contact:
Chemspec International Ltd.
In Shanghai
Bing Zhu
Chief Financial Officer
Tel: +86-21-6363-8108
Email: ir@chemspec.com.cn
Christensen
In New York
Kathy Li
Tel: +1-212-618-1978
Email: kli@christensenir.com
In Hong Kong
Tip Fleming
Tel: +852-9212-0684
Email: tfleming@christensenir.com
SOURCE Chemspec International Limited
Chemspec International Ltd. - In Shanghai, Bing Zhu, Chief Financial Officer,
+86-21-63638108, or ir@chemspec.com.cn; Christensen - In New York, Kathy Li,
+1-212-618-1978, or kli@christensenir.com; In Hong Kong, Tip Fleming,
+852-9212-0684, or tfleming@christensenir.com
